The major criteria include the presence of chronic cutaneous lupus erythematosus; EM-like lesions; at least one positivity among speckled ANA, anti-Ro/SSA, and anti-La/SSB antibodies; and negative DIF of EM-like lesions [1]. This evidence concerns the gene BTG3 and erythema multiforme.